publication date: Dec. 3, 2010

In this issue:

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar and Avodart Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase CTI Files Appeal Over FDA’s Decision on Pixantrone NIH Defends NCI Sponsored Travel Obituary: NCI’s Elaine Ron, Expert in Radiation Heath Effects   Download PDF
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.